| Primary |
| Depression |
24.3% |
| Drug Use For Unknown Indication |
17.8% |
| Product Used For Unknown Indication |
15.8% |
| Obsessive-compulsive Disorder |
9.9% |
| Anxiety |
5.3% |
| Major Depression |
5.3% |
| Schizoaffective Disorder |
3.3% |
| Sleep Disorder |
2.6% |
| Narcolepsy |
2.0% |
| Panic Disorder |
2.0% |
| Parathyroid Tumour |
2.0% |
| Schizophrenia |
2.0% |
| Affective Disorder |
1.3% |
| Depressive Symptom |
1.3% |
| Hypertension |
1.3% |
| Serum Ferritin Decreased |
1.3% |
| Abnormal Behaviour |
0.7% |
| Accidental Exposure |
0.7% |
| Assisted Fertilisation |
0.7% |
| Bipolar Disorder |
0.7% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
12.7% |
| Serotonin Syndrome |
9.1% |
| Foetal Exposure During Pregnancy |
7.3% |
| Ventricular Tachycardia |
7.3% |
| Angioedema |
5.5% |
| Maternal Exposure During Pregnancy |
5.5% |
| Respiratory Failure |
5.5% |
| Dizziness |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Feeding Disorder Neonatal |
3.6% |
| Haematemesis |
3.6% |
| Hallucination, Auditory |
3.6% |
| Hypoventilation |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Overdose |
3.6% |
| Palpitations |
3.6% |
| Pancreatitis |
3.6% |
| Prolonged Labour |
3.6% |
| Renal Failure Acute |
3.6% |
| Sinus Tachycardia |
3.6% |
|
| Secondary |
| Depression |
16.3% |
| Product Used For Unknown Indication |
13.8% |
| Drug Use For Unknown Indication |
10.0% |
| Major Depression |
8.2% |
| Alcoholism |
7.0% |
| Anxiety |
5.4% |
| Schizophrenia |
5.4% |
| Hypertension |
5.2% |
| Blood Cholesterol Increased |
4.9% |
| Obsessive-compulsive Disorder |
4.8% |
| Type 2 Diabetes Mellitus |
4.6% |
| Constipation |
3.8% |
| Postpartum Depression |
1.9% |
| Self Injurious Behaviour |
1.7% |
| Suicide Attempt |
1.4% |
| Schizoaffective Disorder |
1.3% |
| Bipolar Disorder |
1.1% |
| Drug Exposure During Pregnancy |
1.1% |
| Intentional Overdose |
1.1% |
| Ill-defined Disorder |
1.0% |
|
| Overdose |
11.8% |
| Completed Suicide |
10.8% |
| White Blood Cell Count Increased |
10.8% |
| Agitation |
5.9% |
| Coma Scale Abnormal |
5.9% |
| Suicidal Ideation |
4.9% |
| Vomiting |
4.9% |
| Pulmonary Embolism |
3.9% |
| Pyrexia |
3.9% |
| Rhabdomyolysis |
3.9% |
| Status Epilepticus |
3.9% |
| Therapy Non-responder |
3.9% |
| Ventricular Tachycardia |
3.9% |
| Weight Increased |
3.9% |
| Aphasia |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
| Multi-organ Failure |
2.9% |
| Serotonin Syndrome |
2.9% |
| Toxicity To Various Agents |
2.9% |
| Tremor |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.6% |
| Drug Use For Unknown Indication |
16.5% |
| Depression |
12.0% |
| Obsessive-compulsive Disorder |
6.7% |
| Schizophrenia |
5.8% |
| Hypertension |
4.6% |
| Hiv Infection |
4.4% |
| Anxiety |
4.0% |
| Diffuse Large B-cell Lymphoma |
2.8% |
| Pain |
2.6% |
| Bipolar Disorder |
2.2% |
| Diabetes Mellitus |
2.2% |
| Narcolepsy |
2.2% |
| Insomnia |
2.1% |
| Restless Legs Syndrome |
2.0% |
| Crohn's Disease |
1.6% |
| Prophylaxis |
1.6% |
| Constipation |
1.5% |
| Social Phobia |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
|
| Morbid Thoughts |
11.2% |
| Suicidal Ideation |
10.4% |
| Vomiting |
8.2% |
| Withdrawal Syndrome |
7.5% |
| Sedation |
6.0% |
| Ventricular Tachycardia |
5.2% |
| Weight Increased |
5.2% |
| Death |
4.5% |
| Tachycardia |
4.5% |
| Weight Decreased |
4.5% |
| Drug Interaction |
3.7% |
| General Physical Health Deterioration |
3.7% |
| Pancreatitis |
3.7% |
| Psychotic Disorder |
3.7% |
| Cardiomyopathy |
3.0% |
| Deep Vein Thrombosis |
3.0% |
| Depression |
3.0% |
| Dysarthria |
3.0% |
| Dyskinesia |
3.0% |
| Maternal Exposure During Pregnancy |
3.0% |
|
| Interacting |
| Depression |
29.9% |
| Ill-defined Disorder |
13.4% |
| Obsessive-compulsive Disorder |
9.0% |
| Drug Use For Unknown Indication |
7.5% |
| Attention Deficit/hyperactivity Disorder |
4.5% |
| Agitation |
3.0% |
| Anxiety |
3.0% |
| Bipolar Disorder |
3.0% |
| Hypervigilance |
3.0% |
| Major Depression |
3.0% |
| Onychomycosis |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Psoriasis |
3.0% |
| Sleep Disorder |
3.0% |
| Bone Pain |
1.5% |
| Cardiovascular Disorder |
1.5% |
| Constipation |
1.5% |
| Disturbance In Attention |
1.5% |
| Dizziness |
1.5% |
| Insomnia |
1.5% |
|
| Drug Interaction |
21.1% |
| Renal Impairment |
15.8% |
| Electrocardiogram Qt Prolonged |
10.5% |
| Overdose |
10.5% |
| Decreased Appetite |
5.3% |
| Mobility Decreased |
5.3% |
| Obsessive-compulsive Disorder |
5.3% |
| Renal Disorder |
5.3% |
| Serotonin Syndrome |
5.3% |
| Suicide Attempt |
5.3% |
| Weight Decreased |
5.3% |
| Withdrawal Syndrome |
5.3% |
|
